Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks

Page 7 of 11

5. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Number of Hedge Fund Holders In Q4 2024: 68

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a biotechnology company primarily known for its treatment for age-related macular degeneration. The firm made quite a splash in May when it announced that it would acquire bankrupt DNA company 23andMe. Cramer was impressed by the deal that sent 23andMe’s pink sheet shares up by 261%. Here’s what he said:

“One of the things that Jensen’s been talking about . . is you need AI tools to be able to look at if you can at the correlations between genetics and disease and health for a large number of people. So what did Regeneron do today? It bought 23andMe for 256 million dollars in order to be able to get those correlations. I think it’s a very smart deal, you may think that they overpaid, but to have AI and that? You may be able to find specific patterns. And that’s what, uh, smart people are doing with AI. So I think that Leonard Schleifer’s gonna do that.

“No I don’t know but I know that it turned out to be worth a lot more than people thought! And I think that one of the things we’ve seen over and over again is this that you use NVIDIA to find out specific patterns about what you see. Particularly for cancer.”

Page 7 of 11